UK markets closed

AbCellera Biologics Inc. (ABCL)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
3.8150+0.0750 (+2.01%)
As of 01:22PM EDT. Market open.
Currency in USD
Earnings estimateCurrent qtr. (Jun 2024)Next qtr. (Sep 2024)Current year (2024)Next year (2025)
No. of analysts5554
Avg. Estimate-0.14-0.14-0.57-0.6
Low estimate-0.16-0.16-0.64-0.78
High estimate-0.13-0.13-0.52-0.42
Year ago EPS-0.11-0.1-0.51-0.57
Revenue estimateCurrent qtr. (Jun 2024)Next qtr. (Sep 2024)Current year (2024)Next year (2025)
No. of analysts7785
Avg. Estimate10.02M10.29M39.97M52.63M
Low estimate7.75M7.7M33.4M37.7M
High estimate11.57M12.4M46.3M68.7M
Year ago sales10.06M11.84M38.02M39.97M
Sales growth (year/est)-0.40%-13.10%5.10%31.70%
Earnings history29/06/202329/09/202330/12/202330/03/2024
Est. EPS-0.13-0.13-0.13-0.17
Actual EPS-0.11-0.1-0.17-0.14
Difference0.020.03-0.040.03
Surprise %15.40%23.10%-30.80%17.60%
EPS trendCurrent qtr. (Jun 2024)Next qtr. (Sep 2024)Current year (2024)Next year (2025)
Current estimate-0.14-0.14-0.57-0.6
7 days ago-0.16-0.16-0.63-0.69
30 days ago-0.15-0.16-0.64-0.69
60 days ago-0.15-0.16-0.64-0.69
90 days ago-0.13-0.14-0.61-0.67
EPS revisionsCurrent qtr. (Jun 2024)Next qtr. (Sep 2024)Current year (2024)Next year (2025)
Up last 7 days111N/A
Up last 30 days3333
Down last 7 daysN/AN/AN/AN/A
Down last 30 daysN/AN/AN/AN/A
Growth estimatesABCLIndustrySector(s)S&P 500
Current qtr.-27.30%N/AN/AN/A
Next qtr.-40.00%N/AN/AN/A
Current year-11.80%N/AN/AN/A
Next year-5.30%N/AN/AN/A
Next 5 years (per annum)10.00%N/AN/AN/A
Past 5 years (per annum)N/AN/AN/AN/A